Related Experiment Video
Updated: Jun 25, 2026
Inverse Probability of Treatment Weighting (Propensity Score) using the Military Health System Data Repository and National Death Index
Published on: January 8, 2020
Characterization of the DMD/BMD patient population in Czech Republic and Slovakia using an innovative registry
Petr Brabec1, Petr Vondrácek, Daniel Klimes
1Institute for Biostatistics and Analyses, Masaryk University, Kamenice 126/3, 625 00 Brno, Czech Republic.
Abstract:
Effective planning of clinical trials requires an appropriate number of patients who fulfil given inclusion criteria. In the case of so called "orphan" diseases, such as Duchenne and Becker muscular dystrophy (DMD/BMD), the number of suitable patients within one country is usually limited. We developed a detailed registry of Czech and Slovak DMD/BMD patients which may contribute to cooperation on the European level. The registry uses internet and database technologies with a multilevel architecture. Patients may view their own data. As of May 2008, 163 patients have been registered in the database. The registry provides a detailed phenotypic and genotypic description of patients. The main purpose of such a registry is the time-effective recruitment of eligible patients for a clinical trial or therapy and may allow the anticipation of possible future effects of appropriate therapy on individual patients. The importance of the DMD/BMD patient registries has recently also been rising with new clinical trials focused on mutation-specific approaches. Other outputs include assessment of epidemiology, phenotype and genotype relationships, or standards of care.
Insights
A new patient registry for Duchenne and Becker muscular dystrophy (DMD/BMD) in Czech and Slovak populations facilitates clinical trial recruitment. This resource aids in understanding disease epidemiology and treatment outcomes for rare neuromuscular disorders.
Area of Science:
- Neurology
- Genetics
- Clinical Research
Background:
- Clinical trial planning for rare diseases like Duchenne and Becker muscular dystrophy (DMD/BMD) is challenging due to limited patient numbers within single countries.
- Effective patient recruitment is crucial for the success of clinical trials and therapeutic development in these orphan diseases.
Purpose of the Study:
- To develop a comprehensive registry of Duchenne and Becker muscular dystrophy (DMD/BMD) patients in the Czech and Slovak Republics.
- To facilitate European-level cooperation and streamline patient recruitment for clinical trials.
- To provide a detailed phenotypic and genotypic description of registered patients.
Main Methods:
- Development of an internet-based registry utilizing multilevel database architecture.
- Inclusion of detailed phenotypic and genotypic patient data.
- Implementation of patient access to their own data.
Main Results:
- As of May 2008, 163 patients with DMD/BMD were registered.
- The registry enables time-effective recruitment of eligible patients for trials and therapies.
- The database supports epidemiological assessments and genotype-phenotype relationship studies.
Conclusions:
- The DMD/BMD patient registry is a valuable tool for advancing research and treatment strategies for these rare neuromuscular conditions.
- Registries are increasingly important for mutation-specific clinical trials and understanding disease progression.
- This initiative can enhance cooperation and data sharing across European research efforts.
